(Q43771149)

26 November 2017

title

Peripheral urocortin inhibits gastric emptying and food intake in mice: differential role of CRF receptor 2. (English)

1 reference

26 November 2017

4

Taché Y

1 reference

26 November 2017

Wang L

1

1 reference

26 November 2017

Martínez V

series ordinal

2

1 reference

26 November 2017

Rivier JE

series ordinal

3

1 reference

26 November 2017

publication date

1 November 2001

1 reference

American Journal of Physiology - Regulatory, Integrative and Comparative Physiology

26 November 2017

published in

1 reference

26 November 2017

volume

281

1 reference

26 November 2017

issue

5

1 reference

26 November 2017

page(s)

R1401-10

1 reference

Human CRF2 alpha and beta splice variants: pharmacological characterization using radioligand binding and a luciferase gene expression assay

26 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.2001.281.5.R1401

Urocortin reduces food intake and gastric emptying in lean and ob/ob obese mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.2001.281.5.R1401

Neuronal pathways involved in abdominal surgery-induced gastric ileus in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.2001.281.5.R1401

Synergistic interaction between leptin and cholecystokinin to reduce short-term food intake in lean mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.2001.281.5.R1401

Peripheral bombesin induces c-fos protein in the rat brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.2001.281.5.R1401

Modulation of urocortin-induced hypophagia and weight loss by corticotropin-releasing factor receptor 1 deficiency in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.2001.281.5.R1401

Urocortin protects against ischemic and reperfusion injury via a MAPK-dependent pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.2001.281.5.R1401

Pituitary-adrenal and vagus modulation of sauvagine- and CRF-induced inhibition of gastric emptying in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.2001.281.5.R1401

Identification of a seven transmembrane helix receptor for corticotropin-releasing factor and sauvagine in mammalian brain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.2001.281.5.R1401

Abnormal adaptations to stress and impaired cardiovascular function in mice lacking corticotropin-releasing hormone receptor-2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.2001.281.5.R1401

Corticotropin-releasing factor receptors: an overview

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.2001.281.5.R1401

Cloning and characterization of human urocortin

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.2001.281.5.R1401

The discovery of 4-(3-pentylamino)-2,7-dimethyl-8-(2-methyl-4-methoxyphenyl)-pyrazolo-[1 ,5-a]-pyrimidine: a corticotropin-releasing factor (hCRF1) antagonist

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.2001.281.5.R1401

Corticotropin releasing factor (CRF) receptor modulators: progress and opportunities for new therapeutic agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.2001.281.5.R1401

Urocortin mRNA is expressed in the enteric nervous system of the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.2001.281.5.R1401

4-(1,3-Dimethoxyprop-2-ylamino)-2,7-dimethyl-8-(2, 4-dichlorophenyl)pyrazolo[1,5-a]-1,3,5-triazine: a potent, orally bioavailable CRF(1) receptor antagonist

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.2001.281.5.R1401

125I-Antisauvagine-30: a novel and specific high-affinity radioligand for the characterization of corticotropin-releasing factor type 2 receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.2001.281.5.R1401

Peripheral administration of CRF and urocortin: effects on food intake and the HPA axis in the marsupial Sminthopsis crassicaudata

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.2001.281.5.R1401

Pretreatment with glucose increases entry of urocortin into mouse brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.2001.281.5.R1401

Activation of urocortin transport into brain by leptin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.2001.281.5.R1401

Peripheral administration of urocortin suppresses operant responding for food reward.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.2001.281.5.R1401

Peripheral corticotropin-releasing factor and stress-stimulated colonic motor activity involve type 1 receptor in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.2001.281.5.R1401

Urocortin and corticotropin-releasing factor receptor expression in the human colonic mucosa

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.2001.281.5.R1401

Effects of sauvagine, urotensin I and CRF on food intake in rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.2001.281.5.R1401

Distribution and concentration of urocortin, and effect of adrenalectomy on its content in rat hypothalamus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.2001.281.5.R1401

Identification of a second corticotropin-releasing factor receptor gene and characterization of a cDNA expressed in heart

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.2001.281.5.R1401

Cholecystokinin inhibits gastric motility and emptying via a capsaicin-sensitive vagal pathway in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.2001.281.5.R1401

Astressin analogues (corticotropin-releasing factor antagonists) with extended duration of action in the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.2001.281.5.R1401

Constrained corticotropin releasing factor antagonists (astressin analogues) with long duration of action in the rat

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.2001.281.5.R1401

Structural requirements for peptidic antagonists of the corticotropin-releasing factor receptor (CRFR): development of CRFR2beta-selective antisauvagine-30

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.2001.281.5.R1401

CP-154,526: a potent and selective nonpeptide antagonist of corticotropin releasing factor receptors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.2001.281.5.R1401

The neurobiology of urocortin

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.2001.281.5.R1401

The role of CRF2 receptors in corticotropin-releasing factor- and urocortin-induced anorexia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.2001.281.5.R1401

Urocortin, a mammalian neuropeptide related to fish urotensin I and to corticotropin-releasing factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.2001.281.5.R1401

Fos expression in the brain induced by peripheral injection of CCK or leptin plus CCK in fasted lean mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.2001.281.5.R1401

10.1152/AJPREGU.2001.281.5.R1401

21 January 2018

Identifiers

DOI

0 references

1 reference